Webinar - Dr Erika Spaeth to interview A/Prof Charles Siles on risk assessment tests for serious disease
10 nov. 2022 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies (ASX:GTG, NASDAQ:GENE), a global leader in guideline driven Genomics based tests in health, wellness and serious disease...
Genetype for Ovarian Cancer Published in Prestigious European Journal of Cancer Prevention
09 nov. 2022 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in guideline driven genomics-based tests in health,...
Genetic Technologies Announces Q1 FY23 Quarterly Results and Investor Webinar Details
25 oct. 2022 09h14 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in guideline-driven genomics-based tests in health,...
Journal of Precision Medicine publication confirms GeneType Risk Test outperforms traditional risk assessments for breast cancer
29 sept. 2022 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and...
Genetic Technologies Provides Update on US Operations and Payer Engagement
02 sept. 2022 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Sept. 02, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”, “GENE”), a global leader in guideline driven genomics-based tests in...
GENE Momentum building - a year in review
30 août 2022 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in guideline driven genomics-based tests in health,...
Gene achieves key milestones and growth
28 juil. 2022 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, July 28, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...
GeneType launches Multi-Test in Obstetrics clinics with more than 1,000 referring primary care physicians
18 juil. 2022 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, July 18, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...
Completion of AffinityDNA Acquisition expanding global direct-to-consumer business
14 juil. 2022 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, July 14, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...
EasyDNA expands Indian and European markets; launching NIPT, Carrier testing and DNA storage
05 juil. 2022 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, July 05, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and...